A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis

Osteoarthritis and Cartilage

Volumn 18, Issue 5, 2010, Pages 699-704

  Valdes, A M ^a   Arden, N K ^b,c   Tamm, A ^d   Kisand, K ^d   Doherty, S ^e   Pola, E ^f   Cooper, C ^b,c   Muir, K R ^g   Kerna, I ^d   Hart, D ^a   O'Neil, F ^a   Zhang, W ^e   Spector, T D ^a   Maciewicz, R A ^h   Doherty, M ^e  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF TARTU   (Estonia)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF WARWICK   (United Kingdom)

^h ASTRAZENECA   (United Kingdom)

Author keywords

Genetic susceptibility; Interleukin 6; Meta analysis

Indexed keywords

INTERLEUKIN 6;

ARTICLE; ESTONIA; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIP OSTEOARTHRITIS; HUMAN; ITALY; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOMATOLOGY; UNITED KINGDOM;

COHORT STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; LINKAGE (GENETICS); OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 77952551250     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.12.012     Document Type: Article

References (23)

1. Samuels J., Krasnokutsky S., Abramson S.B. Osteoarthritis: a tale of three tissues. Bull NYU Hosp Jt Dis 2008, 66(3):244-250.
2. Goldring S.R., Goldring M.B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004, 427(Suppl):S27-S36.
3. Kaneko S., Satoh T., Chiba J., Ju C., Inoue K., Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000, 6:71-79.
4. Sakao K., Takahashi K.A., Arai Y., Saito M., Honjo K., Hiraoka N., et al. Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis. J Bone Miner Metab 2009, 27(4):412-423.
5. Livshits G., Zhai G., Hart D.J., Kato B.S., Wang H., Williams F.M., et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford study. Arthritis Rheum 2009, 60(7):2037-2045.
6. Marinou I., Healy J., Mewar D., Moore D.J., Dickson M.C., Binks M.H., et al. Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum 2007, 56(8):2549-2556.
7. Gordon A., Kiss-Toth E., Stockley I., Eastell R., Wilkinson J.M. Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum 2008 Oct, 58(10):3157-3165.
8. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
9. Kämäräinen O.P., Solovieva S., Vehmas T., Luoma K., Riihimäki H., Ala-Kokko L., et al. Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res Ther 2008, 10(1):R21.
10. Pola E., Papaleo P., Pola R., Gaetani E., Tamburelli F.C., Aulisa L., et al. Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: a case-control study. Osteoarthritis Cartilage 2005, 13(11):1025-1028.
11. Limer K.L., Tosh K., Bujac S.R., McConnell R., Doherty S., Nyberg F., et al. Attempt to replicate published genetic associations in a large, well-defined osteoarthritis case-control population (the GOAL study). Osteoarthritis Cartilage 2009, 17(6):782-789.
12. Valdes A.M., Spector T.D., Doherty S., Wheeler M., Hart D.J., Doherty M. Association of the DVWA and GDF5 polymorphisms with osteoarthritis in UK populations. Ann Rheum Dis 2009, 68(12):1916-1920.
13. Syddall H.E., Aihie Sayer A., Dennison E.M., Martin H.J., Barker D.J., Cooper C. Cohort profile: the Hertfordshire cohort study. Int J Epidemiol 2005, 34(6):1234-1242.
14. Tamm A., Lintrop M., Veske K., Hansen Ü, Tamm A. Prevalence of patello- and tibiofemoral osteoarthritis in Elva, Southern Estonia. J Rheumatology 2008, 35(3):543-544.
15. Hart D.J., Spector T.D. The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study. J Rheumatol 1993, 20(2):331-335.
16. Engels E.A., Schmid C.H., Terrin N., Olkin I., Lau J. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med 2000, 19(13):1707-1728.
17. Kerna I., Kisand K., Tamm A.E., Lintrop M., Veske K., Tamm A.O. Missense single nucleotide polymorphism of the ADAM12 gene is associated with radiographic knee osteoarthritis in middle-aged Estonian cohort. Osteoarthritis Cartilage 2009, 17(8):1093-1098.
18. van de Loo F.A., Joosten L.A., van Lent P.L., Arntz O.J., van den Berg W.B. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995, 38:164-172.
19. de Hooge A.S., van de Loo F.A., Bennink M.B., Arntz O.J., de Hooge P., van den Berg W.B. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging. Osteoarthritis Cartilage 2005, 13(1):66-73.
20. Hashizume M., Mihara M. Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production. Osteoarthritis Cartilage 2009, 17(11):1513-1518.
21. Cronstein B.N. Interleukin-6 - a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007, 65(Suppl 1):S11-S15.
22. Pascual M., Nieto A., Matarán L., Balsa A., Pascual-Salcedo D., Martín J. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000, 1:338-340.
23. Pawlik A., Wrzesniewska J., Florczak M., Gawronska-Szklarz B., Herczynska M. IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 2005, 34:109-113.